| Proteomic analysis of a podocyte vesicle-enriched fraction from human normal and pathological urine samples | Proteomics. Clinical applications |  | | 2008 | 654 | 0 |
|
| Deciphering the human nucleolar proteome | Mass spectrometry reviews | | | 2006 | 810 | 0 |
|
| Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid | Journal of proteome research | | | 2006 | 678 | 1 |
|
| MSight: an image analysis software for liquid chromatography-mass spectrometry | Proteomics | | | 2005 | 671 | 0 |
|
| PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke | Clinical chemistry | | | 2005 | 646 | 1 |
|
| Nonredundant mass spectrometry: a strategy to integrate mass spectrometry acquisition and analysis | Proteomics | | | 2004 | 634 | 0 |
|
| ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke | Proteomics | | | 2004 | 667 | 0 |
|
| Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease | Proteomics | | | 2004 | 644 | 0 |
|
| Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration | Proteomics | | | 2004 | 623 | 0 |
|
| Proteomics application exercise of the Swiss Proteomics Society: report of the SPS'02 session | Proteomics | | | 2003 | 673 | 0 |
|
